Sage Therapeutics (SAGE) Stock Highlights

7.59 | +0.93%

2024-09-19 04:26:36

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The companys lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinsons disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development.

Statistics

Range Today

7.32 7.85

Volume Today 652.9K

Range 1 Year

7.19 28.26

Volume 1 Year 248.9M

Range 3 Year

7.19 59.99

Volume 3 Year 605.81M

Range 10 Year

7.19 195.97

Volume 10 Year 1.63B

Highlights

Market Capitalization 478.03M (small)

Floating Shares 48.34M

Current Price 7.59

Price To Earnings -1.01

Price To Revenue -2.02

Price To Book 0.76

Earnings Per Share -7.41

Payout Ratio 0%

Performance

Latest +0.93%

1 Month -7.1%

3 Months -33.13%

6 Months -62.22%

1 Year -63.91%

3 Years -83.1%

5 Years -95.36%

10 Years -71.91%

Benchmarks

Market Capitalization

107 / 368

Gross Profits

272 / 278

Total Revenue

181 / 300

Total Rank

353 / 368

Free Cashflow

338 / 352

Performance 5 years

332 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.